End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)
NCT ID: NCT00374582
Last Updated: 2011-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2006-09-30
2008-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound Quantification of Liver Fat
NCT04523584
Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases Severity
NCT03492879
Changes in Body Composition and Nutritional Status in Patients Undergoing Liver Transplantation
NCT02023190
Analysis of Body Composition in Patients With Hepatocellular Carcinoma in Radioablation
NCT01744639
Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome
NCT03584204
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* 18 years of age or older
* Cirrhotic patients with refractory ascites requiring LVP (a treatment to remove large volumes of excess fluid from the abdominal cavity)
* End Stage Liver Disease
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bodystat Quadscan 4000
device determining body composition and nutritional status
bodystat quadscan 400
device determining body composition and nutritional status
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age over 18.
* Ability to provide written informed consent.
Exclusion Criteria
* Patient with use of any investigational agent within 30 days before LVP.
* Pregnant or lactating.
* Patients with non-bioprosthetic heart valves pacemakers, defibrillators, artificial joints, pins, plates, or other types of metal objects in the body.
* Amputations other than fingers or toes.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Cincinnati
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Cincinnati
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guy Neff, MD
Role: PRINCIPAL_INVESTIGATOR
University of Cincinnati
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Cincinnati
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BIA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.